Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

GLMD Galmed Pharmaceuticals Ltd

2,7299

0,0699 (2,63%)

Zuletzt aktualisiert: 20:02:08

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Galmed Pharmaceuticals (NASDAQ:GLMD)
Historical Stock Chart
Von Jan 2025 bis Feb 2025

Click Here for more Galmed Pharmaceuticals Charts.

Galmed Pharmaceuticals (NASDAQ:GLMD)
Historical Stock Chart
Von Feb 2024 bis Feb 2025

Click Here for more Galmed Pharmaceuticals Charts.

News Galmed Pharmaceuticals Ltd

Form S-8 - Securities to be offered to employees in employee benefit plans
Dienstag 7 Januar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Freitag 22 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 14 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form F-3 - Registration statement by foreign private issuers
Donnerstag 14 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 14 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Montag 28 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form F-1 - Registration statement for certain foreign private issuers
Montag 21 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 21 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 15 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 25 September 2024 (4 Monate vor) • Edgar (US Regulatory)

Galmed publishes Results from Aramchol Phase 3 Open Label part in Hepatology
Mittwoch 25 September 2024 (4 Monate vor) • PR Newswire (US)

Weitere Galmed Pharmaceuticals Ltd News-Artikel

Quorum Information Techn... (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen